# Colgate-Palmolive account plan

> Colgate-Palmolive sells oral, personal and home care products and Hill's pet food worldwide: $20,382 million FY2025 net sales, about 33,600 employees.

## At a glance

Colgate-Palmolive, founded in 1806 and incorporated in Delaware, sells oral care, personal care, home care and pet nutrition products in over 200 countries and territories, through retailers, wholesalers, distributors, dentists, veterinarians and eCommerce. It is the global leader in toothpaste (41.3% global share in 2025) and manual toothbrushes, with brands such as Colgate, elmex, Palmolive, Softsoap, Irish Spring, Ajax, Fabuloso and Hill's Science Diet. FY2025 net sales were $20,382 million (+1.4%); GAAP operating profit fell 23% to $3,306 million after a $919 million impairment of the skin health business, while non-GAAP EPS rose 3% to $3.69. It had about 33,600 employees in over 100 countries at December 31, 2025, and about two-thirds of net sales come from outside the United States. Noel Wallace is Chairman, President and CEO.

## Business units

- **North America (Oral, Personal and Home Care)** (17% of Q3 2026 company sales): Oral, personal and home care in the US and Canada; FY2025 net sales were $4,045 million, down 1.6%. In Q3 2026 net sales fell 1.7% and operating profit fell 11% on raw and packaging costs and higher advertising; management calls the US turnaround a priority.
- **Latin America (Oral, Personal and Home Care)** (25% of Q3 2026 company sales): The highest-margin division, led by Mexico, Brazil and Argentina in oral care and surface cleaners; FY2025 net sales were $4,776 million with organic growth of 3.9%. In Q3 2026 net sales rose 12.5% (organic +6.0%) with a 29.6% operating margin.
- **Europe, Middle East & Africa (Oral, Personal and Home Care)** (21% of Q3 2026 company sales): Formed from Q1 2026 by combining Europe, Africa/Eurasia (excluding Russia and Belarus) and the skin health business (EltaMD, Filorga, PCA SKIN). Q3 2026 organic growth was 2.7%, led by Türkiye, the United Kingdom and Spain, and operating profit rose 8%; premium brands such as elmex and Colgate Total drive share.
- **Asia Pacific (Oral, Personal and Home Care)** (15% of Q3 2026 company sales): Toothpaste and toothbrushes across India, the Greater China region (including Hawley & Hazel) and South East Asia, now also covering Russia and Belarus. Q3 2026 organic growth was 4.6%, with India up double digits, while the operating margin fell to 26.4%.
- **Hill's Pet Nutrition** (23% of FY2025 net sales ($4,613 million)): Hill's Science Diet, Hill's Prescription Diet therapeutic foods and Prime100 fresh pet food, sold through pet retailers, veterinarians and eCommerce in over 80 countries. FY2025 operating profit rose 10% to $1,064 million; Q3 2026 organic growth was 5.7% as Hill's exits private label and rolls out Fresh single-protein diets.

## Strategic priorities

- **2030 strategy**: Brand reach and penetration, science-based premium innovation, omni-channel demand generation, leadership in data, analytics and AI, and culture, prioritising Oral Care, Personal Care and Pet Nutrition.
- **US turnaround**: Repowering the marketing model, a faster premium innovation pipeline (Optic White Pro Series, Fabuloso) and a go-to-market rebuilt for digital, agentic and social commerce channels.
- **Premiumisation**: Growth is in super premium toothpaste such as elmex, where Colgate says it is under-indexed in North America; Hill's grows through therapeutic and wellness diets.
- **Productivity to fund advertising**: The Strategic Growth and Productivity Program was expanded on April 30, 2026 to $350-$550 million of pretax charges and $200-$300 million of annualised pretax savings by 2028; savings are reinvested in advertising, AI and data.
- **AI at scale**: PromoAI is scaled across key markets, a proprietary AI innovation platform speeds product ideation, and about 70% of VPs have advanced AI training.

## Latest results

In Q3 2026 (quarter to September 30) net sales rose 4.6% to $5,369 million, with organic growth of 3.6% and volume up 1.7%. Gross margin rose 80 bps to 60.2% as funding-the-growth savings offset raw and packaging inflation, advertising rose 15% to $775 million, and Base Business EPS rose 7% to $0.97. Over nine months net sales were $16,055 million (+6.0%) and operating cash flow $2,913 million. FY2026 guidance was narrowed and raised to net sales growth of 4% to 5% and Base Business EPS growth of 5% to 7%, while management expects category softness to continue through the rest of 2026.

## Investments and deals

- **Prime100 acquisition**: Acquired the Australian fresh pet food brand on April 30, 2025 for AU $471 million (about $301 million), Hill's entry into fresh pet food.
- **Strategic Growth and Productivity Program**: Approved July 31, 2025 and expanded April 30, 2026; cumulative charges reached $346 million, 70%-80% employee-related, with EMEA expected to take 25%-30% of charges.
- **Capex and advertising**: Capex was $564 million in 2025, with 2026 capex expected at about 3.0% of net sales; advertising was $2,703 million in 2025 and $2,286 million in the first nine months of 2026.
- **Shareholder returns**: A $5 billion repurchase program was authorised March 20, 2025; the quarterly dividend was raised to $0.53 per share.

## Challenges and risks

- **Raw material and logistics inflation**: Cost inflation is about $300 million for 2026, with resins, petrochemicals, pulp and freight remaining a headwind into 2027.
- **North American weakness**: North America declined in 2025 and in Q3 2026, with category softness, heightened competition and retailer inventory reductions.
- **Retailer power and private label**: Walmart was about 11% of 2025 net sales; key retailers hold bargaining strength and first-party consumer data, and consumers may trade down to private label.
- **Currency and tariffs**: FX in hyper-inflationary Argentina, Nigeria and Türkiye, tariffs and the USMCA renegotiation, and the Middle East conflict affecting freight, oil and resin costs.
- **Skin health underperformance**: A $919 million pretax impairment was taken in 2025 on the skin health business, mainly Filorga, weak in China.

## What leadership says

> "we built our go-to-market for a world of channels, and what we're seeing today is a world that runs on connections." — Noel Wallace, Chairman, President and CEO, Q3 2026 earnings call, October 30, 2026

> "The goal is not simply to manage through volatility. It is to emerge with a stronger business and an even more resilient business moving forward." — Noel Wallace, Chairman, President and CEO, Q3 2026 earnings call, October 30, 2026

> "There'll have to be some pricing to offset some of the raw material and logistics headwinds that everyone is faced with." — Noel Wallace, Chairman, President and CEO, Q3 2026 earnings call, October 30, 2026

> "roughly 300 basis points of a headwind" — Stan Sutula, CFO, Q3 2026 earnings call, October 30, 2026, on material prices


## Where a supplier can help

- **Retail media and social commerce**: The US turnaround and the rebuilt go-to-market for digital, agentic and social commerce channels call for retail media, creator and commerce-platform partners.
- **Procurement and packaging savings**: Funding-the-growth (raw material substitution, packaging reduction, supplier consolidation) offsets about $300 million of cost inflation, so alternative materials and packaging suppliers have a direct entry point.
- **AI and data for marketing**: With PromoAI, an AI innovation platform and agent-ready data, AI tooling for promotions, content and personalisation fits the stated AI priority.
- **Productivity programme services**: The expanded productivity program with $200-$300 million of targeted savings, much of it in EMEA, creates demand for supply-chain optimisation and shared-services support.
- **Hill's fresh pet food scale-up**: The methodical rollout of Fresh through 2027 and Prime100's growth need cold-chain logistics, fresh manufacturing and veterinary-channel partners.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Form 10-K for fiscal year 2025](https://www.sec.gov/Archives/edgar/data/21665/000002166526000006/cl-20251231.htm)

Annual report · 2026-02-23

- Colgate-Palmolive is a consumer-products group founded in 1806, selling in over 200 countries and territories through two product segments: Oral, Personal and Home Care, and Hill's Pet Nutrition; about 33,600 employees in over 100 countries at December 31, 2025.
- FY2025 Net sales were $20,382 million, up 1.4% (pricing +2.1%, volume -0.4%, FX -0.3%); organic sales +1.4%. Oral Care was 44% of Net sales, Personal Care 17%, Home Care 16% and Pet Nutrition 23%.
- Global leader in toothpaste (41.3% global share in 2025, down 0.4 points) and manual toothbrushes (32.4%, up 0.4 points); Walmart represented about 11% of Net sales.
- GAAP operating profit fell 23% to $3,306 million after a $919 million pretax impairment of the skin health business (mainly Filorga, weak in China); non-GAAP operating profit was $4,347 million (21.3% margin). GAAP EPS $2.63; non-GAAP EPS up 3% to $3.69.
- Gross margin fell to 60.1% from 60.5%: raw and packaging costs cost 420 bps, offset by funding-the-growth savings (260 bps), pricing (80 bps) and mix (30 bps). Advertising was $2,703 million, 13.3% of sales.
- The 2025 plan concluded; the 2030 strategy rests on brand reach, science-based premium innovation, omni-channel demand generation, data/analytics/AI leadership and culture. A Strategic Growth and Productivity Program (approved July 31, 2025) carries $200-$300 million of pretax charges through 2028.
- Acquired Prime100 (fresh pet food, Australia) for AU $471 million (about $301 million) on April 30, 2025.
- Cash from operations $4,198 million; capex $564 million (about 3.0% of sales planned for 2026); dividends $1,823 million and $1,210 million of share repurchases; a new $5 billion buyback authorised March 20, 2025.
- The company expects category softness seen in 2025 to continue into 2026, with tariffs, raw-material inflation, FX volatility (Argentina, Nigeria, Türkiye) and private label/retailer power as key risks.

### [Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/21665/000002166526000048/cl-20260930.htm)

Interim report · 2026-10-30

- Q3 2026 (quarter to September 30) Net sales $5,369 million, +4.6% (volume +1.7%, pricing +2.0%, FX +1.0%); organic sales +3.6%, including a 20 bps drag from lower private label pet food sales.
- Gross margin 60.2% (+80 bps); funding-the-growth savings (290 bps), pricing (80 bps) and mix (20 bps) offset raw and packaging inflation (300 bps).
- Advertising rose 15% to $775 million, 14.4% of sales; operating profit +3% to $1,088 million (non-GAAP $1,117 million, +5%); EPS $0.94 (non-GAAP $0.97, +7%).
- New segment structure since Q1 2026: North America, Latin America, Europe Middle East & Africa (EMEA, including skin health), Asia Pacific, and Hill's Pet Nutrition.
- Latin America led (+12.5% reported, organic +6.0%, margin 29.6%); North America declined (-1.7%, organic -1.6%, operating profit -11%).
- Hill's Q3 Net sales $1,205 million, organic +5.7%, on therapeutic and wellness growth.
- Nine months: Net sales $16,055 million (+6.0%), organic +3.0%; non-GAAP EPS $2.94 (+7%); operating cash flow $2,913 million (+6%).
- The Strategic Growth and Productivity Program was expanded on April 30, 2026: $350-$550 million pretax charges and $200-$300 million annualised pretax savings by 2028; $346 million charged to date.
- Global toothpaste share 41.4% year to date (+0.3 points) and manual toothbrush 33.1% (+0.8 points). Management expects category softness through the rest of 2026.

### [Colgate-Palmolive Announces 3rd Quarter 2026 Results (press release)](https://www.sec.gov/Archives/edgar/data/21665/000002166526000047/q32026pressreleasetables.htm)

Interim report · 2026-10-30

- Q3 2026 Net sales +4.6% to $5,369 million; organic sales +3.6%; GAAP EPS +3% to $0.94, Base Business EPS +7% to $0.97.
- Gross margin +80 bps to 60.2% (Base Business 60.3%, +90 bps); nine-month operating cash flow $2,913 million.
- Q3 share of company sales: Latin America 25%, Hill's 22%, Europe Middle East & Africa 21%, North America 17%, Asia Pacific 15%.
- Organic growth by division: Latin America +6.0%, Hill's +5.7%, Asia Pacific +4.6%, EMEA +2.7%, North America -1.6%. Emerging markets organic +5.4%, developed +2.3%.
- FY2026 guidance narrowed and raised: net sales +4% to 5% (was 2% to 6%), organic growth broadly in line with nine-month performance (was 1% to 4%), gross margin up (was roughly flat), Base Business EPS growth 5% to 7% (was mid-single digit), GAAP EPS growth double-digit.
- Noel Wallace (Chairman and CEO): fourth quarter of sequential improvement in worldwide volume, "another double-digit increase in advertising", focus on "premium, science-based innovation" under the 2030 strategy.

### [Q3 2026 earnings call transcript](https://fortune.com/company/colgate-palmolive/earnings/q3-2026/)

Executive talk · Noel Wallace, Chairman, President and Chief Executive Officer · 2026-10-30

- Noel Wallace (Chairman, President and CEO) called Q3 2026 broad-based: organic growth in all four categories and four of five divisions, free cash flow up 7%, and $2.2 billion returned to shareholders year to date.
- Pricing has run ahead of costs: 220 bps in Q1, 160 in Q2 and about 200 in Q3; CFO Stan Sutula put material inflation at about 300 bps of gross margin headwind, offset by over 290 bps of funding-the-growth savings.
- Cost inflation still about "$300± million" for the year; tariffs and commodity inflation peak in Q4, and resins, petrochemicals, pulp and freight remain a headwind into 2027. No 2027 guidance until Q1 next year.
- US turnaround: "repowering our marketing model", premium innovation, AI and data, and a restructured go-to-market for "a world that runs on connections", including digital, social commerce and agentic commerce.
- Global category growth of 1.5%-3% (emerging 3%-5%, developed 1.5%-2%); India up double digits, Colgate China up high single digits, Hawley & Hazel low single digits; Mexico hit by retailer issues.
- Hill's: 6.5% growth ex-private label, Prescription Diet cat up double digits, careful rollout of Fresh single-protein diets; private label exit ends this quarter.
- AI: PromoAI scaled across key markets; a proprietary AI innovation platform has made product ideation "significantly faster"; AI-generated content used in China.

### [Q2 2026 earnings call transcript](https://fortune.com/company/colgate-palmolive/earnings/q2-2026/)

Executive talk · Noel Wallace, Chairman, President and Chief Executive Officer · 2026-07-31

- Noel Wallace (Chairman, President and CEO) on Q2 2026: organic growth in four of five divisions and three of four categories, gross margin expansion before a modest tariff refund benefit, double-digit advertising increase, free cash flow up 18% and $1.4 billion returned to shareholders.
- US performance was unsatisfactory: category softness in May (peak gasoline prices), heightened competition and retailer inventory reductions ("shipping consumption more or less at one, with shipments down three"); remedies are premium innovation (Optic White Pro Series, Fabuloso), surgical price-gap fixes and more brand support.
- Gross margin up 100 bps; full-year gross margin guidance raised to roughly flat; Q3 costs largely locked in, oil assumed "in the $90 range".
- Hill's grew 4% ex-private label against a roughly flat category; Fresh single-protein diets roll out through vets and pet specialty; Prime keeps growing in Australia.
- China: Colgate China delivering mid-single-digit growth; Greater China up mid-single digits while the market may be "down 1%-2%"; Hawley & Hazel up low single digits but "not out of the woods".
- Europe's lesson for the US: the super premium toothpaste segment (elmex) is where growth is, and Colgate is "severely under indexed there in North America".
- AI: about 70% of VPs trained in advanced AI, data rebuilt for agents, PromoAI scaling; the senior team was "vibe coding" this week. John Faucher (EVP M&A and Special Projects) retires end of September.

## Questions about Colgate-Palmolive

### What does Colgate-Palmolive do?

It sells oral care, personal care, home care and pet nutrition products (Hill's) in over 200 countries and territories, and leads the global toothpaste and manual toothbrush markets.

### What is Colgate-Palmolive's revenue?

FY2025 net sales were $20,382 million, up 1.4%. In the first nine months of 2026 net sales were $16,055 million, up 6.0%.

### How many employees does Colgate-Palmolive have?

About 33,600 employees in over 100 countries at December 31, 2025, over 84% of them outside the US.

### What is Colgate-Palmolive's strategy?

The 2030 strategy rests on brand reach, science-based premium innovation, omni-channel demand generation, data, analytics and AI, and culture, funded by a productivity program running to 2028.

### Who leads Colgate-Palmolive?

Noel Wallace is Chairman, President and CEO, and Stanley J. Sutula III is CFO.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
